Valeo Financial Advisors, LLC Cassava Sciences Inc Transaction History

Valeo Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$16.33 - $51.06 $80,049 - $250,296	4,902 New	4,902 $205,000
Q2 2022 Aug 03, 2022	SELL	$17.22 - $38.47 $101,598 - $226,973	-5,900 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$32.6 - $53.05 $32,600 - $53,050	-1,000 Reduced 14.49%	5,900 $219,000
Q4 2021 Jan 07, 2022	BUY	$36.77 - $90.91 $253,713 - $627,279	6,900 New	6,900 $302,000

195

13.7M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.